Pretreatment with nafamostat via the i.n. route either completely prevented or significantly reduced infection-induced weight loss, and substantially reduced viral loads throughout the ensuing course of illness, in Ad5-hACE2 transduced mice and K18-hACE2 mice. This evidence concerns the gene KRT18 and infection.